Nootropil

Nootropil Tác dụng không mong muốn

piracetam

Nhà sản xuất:

UCB

Nhà tiếp thị:

GlaxoSmithKline
Thông tin kê toa chi tiết tiếng Anh
Adverse Reactions
Clinical Trial and Post Marketing Data: Double-blind placebo-controlled clinical or pharmaco-clinical trials, of which quantified safety data are available (extracted from the UCB Documentation Data Bank on June 1997), included more than 3000 subjects receiving piracetam, regardless of indication, dosage form, daily dosage or population characteristics.
Adverse reactions are ranked under headings of frequency using the following convention: Very common ≥1/10; Common ≥1/100 to <1/10; Uncommon ≥1/1000 to <1/100; Rare ≥1/10000 to <1/1000; Very rare <1/10000; Not known (cannot be estimated from the available data).
Blood and lymphatic system disorders: Not known: haemorrhagic disorder.
Immune system disorders: Not known: anaphylactoid reaction, hypersensitivity.
Psychiatric disorders: Common: nervousness.
Uncommon: depression.
Not known: agitation, anxiety, confusion, hallucination.
Nervous system disorders: Common: hyperkinesia.
Uncommon: somnolence.
Not known: ataxia, balance disorder, epilepsy, headache, insomnia.
Ear and labyrinth disorders: Not known: vertigo.
Gastrointestinal disorders: Not known: abdominal pain, abdominal pain upper, diarrhoea, nausea, vomiting.
Skin and subcutaneous tissue disorders: Not known: angioedema, dermatitis, pruritus, urticaria.
General disorders and administration site conditions: Uncommon: asthenia.
Investigations: Common: weight increased.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Đăng nhập
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Đăng nhập